Matthew Perry, ketamine and America's doctor-to-dealer pipeline
![Matthew Perry, ketamine and America's doctor-to-dealer pipeline](https://thehill.com/wp-content/uploads/sites/2/2024/08/perry_matthew_01132017_GettyImages-631611692.jpg?w=900)
Unfortunately, the shadowy world of illicit drug use continues to get many of its ideas and pills directly from the world of medicine. Charges related to “Friends” star Matthew Perry’s October death are our most recent example.
This was certainly true when the opioid epidemic was born and grew, as opium was turned into morphine, which spawned heroin, even as the medical profession was overprescribing opioids for supposed chronic pain. This knee-jerk prescribing fueled a massive amount of illicit use in the first decade of this century.
In the second decade, more physicians became self-aware and more restrictions, including the state of New York’s Internet System for Tracking Over-Prescribing, were put in place to limit and monitor opioid prescribing. But at the same time, fentanyl, another powerful, long-acting opioid conceived to help with chronic pain, including terminal cancer pain, was increasingly co-opted by the drug lords.
The poppy fields in Mexico have mostly dried up and been replaced by fentanyl. Suppliers of ingredients from China have expanded the fentanyl market, leading to more than 70,000 annual overdose deaths in the U.S.
Thanks to fentanyl, carfentanil, xylazine and other drugs, we have entered a dangerous era where people are fed by increasingly potent drugs made in small labs rather than cooked or distilled from plants.
This concept has now expanded to psychedelics. Even as the medical world studies psilocybin, MDMA and ketamine for the legitimate treatment of severe depression, pain relief and PTSD, the grey and black markets are seizing on these drugs for profit.
Matthew Perry’s tragic death did not occur in isolation but is part of a much larger trend, whereby prescriptions of ketamine from supposed health and wellness centers have reportedly increased by 500 percent since 2017.
Ketamine is a general anesthetic which, when overdosed, can cause disorientation, skyrocketing heart rate and blood pressure, slowed breathing and loss of consciousness. In Perry’s case, the side effects may have been just enough for him to slip below the water line in his hot tub and drown, whereas for others, ketamine can directly kill.
This is why it's so disturbing to learn of an alleged drug ring involving the so-called “Ketamine Queen,” Jasveen Sangha, an emergency room physician Dr. Mark Chavez, who reportedly served as a supplier to an internist, Dr. Salvador Plasencia, who then instructed Matthew Perry’s live-in assistant, Kenneth Iwamasa, to administer the drug to Perry.
What is perhaps most disturbing about this deadly cascade is that feeding the psychological addiction of a rich, high-profile client is not something that occurred in isolation but is part of a much larger market where a potentially dangerous drug is deliberately misused by so-called medical professionals and their consorts.
Consider that ketamine use in general anesthesia or an emergency room setting is now standard, whereas it is still being studied for severe depression or PTSD.
Don’t get me wrong: Treatment by the right providers certainly holds promise in terms of breaking depression cycles due to ketamine’s dissociative and euphoric effects on the brain without the negative side effects and stigma of electroconvulsive therapy. The Food and Drug Administration has thus far approved only esketamine, a nasal spray that is only supposed to be given in a medical setting by experienced healthcare providers.
The idea of drug lords supplying the injectable form of the medication, which is not yet approved for the treatment of depression, to doctors who then teach personal assistants to administer it represents a very dangerous situation that is spiraling out of control.
Illicit drug use is nothing new. But we must heavily police and prevent the hijacking of powerful medicines for untested treatments in order to pad pockets. Our Drug Enforcement Agency certainly has its hands full with ketamine, a highly useful medicine only when the right doctors are administering it for the right reasons.
Marc Siegel, M.D., is a professor of medicine and medical director of Doctor Radio at NYU Langone Health. He is a Fox News medical correspondent and author of “COVID; The Politics of Fear and the Power of Science.”
Date: |
-
MarketWatch - Business
Moderna slashes research spending, trims pipeline as it looks to regain footing
Moderna Inc. on Thursday touted progress toward new vaccine approvals but said it will rein in its research and development spending and trim its pipeline as it looks to shake off the doldrums of a ...1 hour ago -
ABC News - Health
Could America's divide on marijuana be coming to an end?
The U.S. is divided when it comes to state and federal marijuana policy, but recent political developments could move the country toward greater acceptance of cannabis5 hours ago -
BBC News - Top stories
Swift makes MTV history while Katy Perry sparkles
Taylor Swift becomes the most-awarded artist in MTV history, while Katy Perry gets the night's main prize.6 hours ago -
ABC News - Entertainment
Taylor Swift wins big at MTV Video Music Awards, ties Beyoncé’s record and thanks Travis Kelce
Taylor Swift has won the biggest award at the MTV Video Music Awards — the trophy for video of the year for “Fortnight,” featuring Post Malone6 hours ago -
The Hill - Politics
Court revives anti-Christian bias claims for school official fired after objecting to Matthew Shepard play
A U.S. Court of Appeals on Tuesday ruled that a former assistant principal may proceed with his religious discrimination lawsuit against his former school district, which he alleges fired him over ...11 hours ago -
Yahoo Sports - Sports
Roman Anthony takes No. 1 spot in Baseball America's prospect rankings
Roman Anthony, the Red Sox' second-round pick in the 2022 draft, is officially the No. 1 ranked prospect in baseball.15 hours ago -
The New York Times - Top stories
Harris and Trump Bet on Their Own Sharply Contrasting Views of America
Former President Donald J. Trump is gambling that Americans are as angry as he is, while Vice President Kamala Harris hopes voters are exhausted by the Trump era and ready to move on.21 hours ago - Donald Trump -
The Hill - Politics
The government cannot solve America’s housing crisis
To effectively address the housing crisis, federal policymakers should consider several market-driven strategies.22 hours ago -
The Guardian - World
Trump’s dour negativity contrasted with Harris’s optimism about America | Robert Reich
Trump tried to paint Harris as the candidate of the status quo, but he failed because he came across as a mess. Get Robert Reich’s latest columns delivered straight to your inbox To say ...23 hours ago -
Inc. - Business
Trump vs. Harris: How the Candidates Want to Reshape Taxes for Corporate America
The two diverge on their vision for how much corporate tax they want to levy on businesses in 2025.Yesterday - Donald Trump
More from The Hill
-
The Hill - Politics
Biden, can you spare a DIME?
President Biden's over-reliance on economic sanctions to deter Russia and Iran has not been effective. He needs to dive into the diplomatic, information and military playbook as well.24 minutes ago - Joe Biden -
The Hill - Politics
Rick Scott to run ad during Miami Dolphins game hitting Mucarsel Powell as a ‘socialist’
Florida Sen. Rick Scott's (R) reelection campaign will run an ad labeling his opponent, former Rep. Debbie Mucarsel Powell, a "silly socialist" during a Miami Dolphins game on Thursday. The ...24 minutes ago -
The Hill - Politics
Morning Report — Post-debate: What’s next for Harris, Trump?
Two days after Vice President Harris and former President Trump faced off in their first presidential debate, one question looms large: Will it move the needle? Pollsters have characterized the ...54 minutes ago - Donald Trump -
The Hill - Politics
GOP senators express frustration with Trump's performance at debate
Senate Republicans are feeling frustrated and disappointed by former President Trump's debate performance and his inability to resist taking the bait from Vice President Harris on side issues such ...1 hour ago - Donald Trump -
The Hill - Politics
What to know about Google's second antitrust trial
Google is on trial for the second time in two years for alleged antitrust violations, as the Department of Justice (DOJ) accuses the tech giant of dominating all sides of the digital advertising ...1 hour ago - Google